These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 10831489

  • 1. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone.
    de Haan L, Lavalaye J, Linszen D, Dingemans PM, Booij J.
    Am J Psychiatry; 2000 Jun; 157(6):1019-20. PubMed ID: 10831489
    [Abstract] [Full Text] [Related]

  • 2. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
    de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D.
    Am J Psychiatry; 2003 Feb; 160(2):303-9. PubMed ID: 12562577
    [Abstract] [Full Text] [Related]

  • 3. In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study.
    Dresel S, Mager T, Rossmüller B, Meisenzahl E, Hahn K, Möller HJ, Tatsch K.
    Eur J Nucl Med; 1999 Aug; 26(8):862-8. PubMed ID: 10436199
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia.
    Lavalaye J, Linszen DH, Booij J, Reneman L, Gersons BP, van Royen EA.
    Psychiatry Res; 1999 Nov 08; 92(1):33-44. PubMed ID: 10688158
    [Abstract] [Full Text] [Related]

  • 5. Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine.
    Schmitt GJ, Meisenzahl EM, Dresel S, Tatsch K, Rossmüller B, Frodl T, Preuss UW, Hahn K, Möller HJ.
    J Psychopharmacol; 2002 Sep 08; 16(3):200-6. PubMed ID: 12236625
    [Abstract] [Full Text] [Related]

  • 6. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol.
    Tauscher J, Küfferle B, Asenbaum S, Fischer P, Pezawas L, Barnas C, Tauscher-Wisniewski S, Brücke T, Kasper S.
    Psychopharmacology (Berl); 1999 Jan 08; 141(2):175-81. PubMed ID: 9952042
    [Abstract] [Full Text] [Related]

  • 7. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S, Tatsch K, Dähne I, Mager T, Scherer J, Hahn K.
    J Nucl Med; 1998 Jul 08; 39(7):1138-42. PubMed ID: 9669383
    [Abstract] [Full Text] [Related]

  • 8. Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia.
    Mizrahi R, Rusjan P, Agid O, Graff A, Mamo DC, Zipursky RB, Kapur S.
    Am J Psychiatry; 2007 Apr 08; 164(4):630-7. PubMed ID: 17403977
    [Abstract] [Full Text] [Related]

  • 9. Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.
    Bernardo M, Parellada E, Lomeña F, Catafau AM, Font M, Gómez JC, López-Carrero C, Gutiérrez F, Pavía J, Salamero M.
    Psychiatry Res; 2001 Aug 25; 107(2):87-97. PubMed ID: 11530275
    [Abstract] [Full Text] [Related]

  • 10. Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.
    Pilowsky LS, Busatto GF, Taylor M, Costa DC, Sharma T, Sigmundsson T, Ell PJ, Nohria V, Kerwin RW.
    Psychopharmacology (Berl); 1996 Mar 25; 124(1-2):148-53. PubMed ID: 8935810
    [Abstract] [Full Text] [Related]

  • 11. Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications.
    Frankle WG, Gil R, Hackett E, Mawlawi O, Zea-Ponce Y, Zhu Z, Kochan LD, Cangiano C, Slifstein M, Gorman JM, Laruelle M, Abi-Dargham A.
    Psychopharmacology (Berl); 2004 Oct 25; 175(4):473-80. PubMed ID: 15083259
    [Abstract] [Full Text] [Related]

  • 12. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S, Zipursky RB, Remington G.
    Am J Psychiatry; 1999 Feb 25; 156(2):286-93. PubMed ID: 9989565
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients.
    Nordström AL, Nyberg S, Olsson H, Farde L.
    Arch Gen Psychiatry; 1998 Mar 25; 55(3):283-4. PubMed ID: 9510228
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia.
    Paquet F, Soucy JP, Stip E, Lévesque M, Elie A, Bédard MA.
    J Neuropsychiatry Clin Neurosci; 2004 Mar 25; 16(1):47-56. PubMed ID: 14990759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.